Last reviewed · How we verify
Gelofusin
At a glance
| Generic name | Gelofusin |
|---|---|
| Also known as | there is no other name |
| Sponsor | Fenerbahce University |
| Modality | Small molecule |
| Therapeutic area | Other |
| Phase | discontinued |
Approved indications
Common side effects
Key clinical trials
- Comparison of R0 Resection Rate Between Cold Snare Polypectomy, Cold Endoscopic Mucosal Resection and Hot Endoscopic Mucosal Resection for 1-2 cm Colorectal Sessile Serrated Lesions: a Randomized Cont (NA)
- NCT02631356 (Phase 4)
- Investigating Brown Adipose Tissue Activation in Humans (NA)
- Hemodynamic Stability During an Induction of Anaesthesia: A Randomized, Non-blinded Study (NA)
- A Multicenter, Randomized, Double-blind, Positive Controlled Clinical Study on the Efficacy and Safety of Succinylated Gelatin Electrolyte Sodium Acetate Injection for Acute Isovolumetric Hemodilution (NA)
- Effectiveness of Cold Biopsy Forceps With Pre-lift for Complete Resection of Colonic Polyps ≤7mm in Size. (N/A)
- Volume Kinetics of Gelofusine 4% During Uncomplicated Vascular Surgery (N/A)
- A Randomized, Phase II Study of Succinylated Gelatin for Prevention of Fluid Retention in Patients With Breast Cancer Receiving Docetaxel Chemotherapy (Phase 2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Gelofusin CI brief — competitive landscape report
- Gelofusin updates RSS · CI watch RSS
- Fenerbahce University portfolio CI